HK1086474A1 - Ultrasound contrast agent dosage formulation - Google Patents
Ultrasound contrast agent dosage formulationInfo
- Publication number
- HK1086474A1 HK1086474A1 HK06106371.0A HK06106371A HK1086474A1 HK 1086474 A1 HK1086474 A1 HK 1086474A1 HK 06106371 A HK06106371 A HK 06106371A HK 1086474 A1 HK1086474 A1 HK 1086474A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- microparticles
- dosage formulation
- vial
- dry powder
- body weight
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 239000002961 echo contrast media Substances 0.000 title 1
- 239000011859 microparticle Substances 0.000 abstract 6
- 230000037396 body weight Effects 0.000 abstract 2
- 239000007789 gas Substances 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 229920000249 biocompatible polymer Polymers 0.000 abstract 1
- 230000036760 body temperature Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000008223 sterile water Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 238000012285 ultrasound imaging Methods 0.000 abstract 1
- 230000002861 ventricular Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Acoustics & Sound (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1781304A | 2004-06-04 | 2004-06-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1086474A1 true HK1086474A1 (en) | 2006-09-22 |
Family
ID=34925364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06106371.0A HK1086474A1 (en) | 2004-06-04 | 2006-06-02 | Ultrasound contrast agent dosage formulation |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1609483B1 (de) |
| AT (1) | ATE461712T1 (de) |
| CY (1) | CY1110151T1 (de) |
| DE (1) | DE602004026164D1 (de) |
| DK (1) | DK1609483T3 (de) |
| ES (1) | ES2340677T3 (de) |
| HK (1) | HK1086474A1 (de) |
| PL (1) | PL1609483T3 (de) |
| PT (1) | PT1609483E (de) |
| SI (1) | SI1609483T1 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6146657A (en) * | 1989-12-22 | 2000-11-14 | Imarx Pharmaceutical Corp. | Gas-filled lipid spheres for use in diagnostic and therapeutic applications |
| US5976501A (en) * | 1996-06-07 | 1999-11-02 | Molecular Biosystems, Inc. | Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion |
| US5837221A (en) * | 1996-07-29 | 1998-11-17 | Acusphere, Inc. | Polymer-lipid microencapsulated gases for use as imaging agents |
| US6045777A (en) * | 1997-06-30 | 2000-04-04 | Acusphere, Inc. | Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases |
-
2004
- 2004-06-15 PL PL04014021T patent/PL1609483T3/pl unknown
- 2004-06-15 PT PT04014021T patent/PT1609483E/pt unknown
- 2004-06-15 SI SI200431400T patent/SI1609483T1/sl unknown
- 2004-06-15 DE DE602004026164T patent/DE602004026164D1/de not_active Expired - Lifetime
- 2004-06-15 EP EP04014021A patent/EP1609483B1/de not_active Expired - Lifetime
- 2004-06-15 ES ES04014021T patent/ES2340677T3/es not_active Expired - Lifetime
- 2004-06-15 AT AT04014021T patent/ATE461712T1/de active
- 2004-06-15 DK DK04014021.2T patent/DK1609483T3/da active
-
2006
- 2006-06-02 HK HK06106371.0A patent/HK1086474A1/xx not_active IP Right Cessation
-
2010
- 2010-06-24 CY CY20101100577T patent/CY1110151T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1609483T3 (da) | 2010-05-31 |
| EP1609483A1 (de) | 2005-12-28 |
| PL1609483T3 (pl) | 2010-08-31 |
| PT1609483E (pt) | 2010-05-06 |
| ES2340677T3 (es) | 2010-06-08 |
| EP1609483B1 (de) | 2010-03-24 |
| SI1609483T1 (sl) | 2010-06-30 |
| ATE461712T1 (de) | 2010-04-15 |
| CY1110151T1 (el) | 2015-01-14 |
| DE602004026164D1 (de) | 2010-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis | |
| CN104662007B (zh) | 胱硫醚‑γ‑裂合酶(CSE)抑制剂 | |
| JP2018529762A (ja) | 異常炎症反応に関連する状態を処置するための方法および組成物 | |
| CN106572993A (zh) | 用于治疗癌症的组合疗法 | |
| TW202128610A (zh) | 醫藥調配物 | |
| CO6311066A2 (es) | Composiciones de alta densidad que contienen posaconazol y formulaciones que comprenden las mismas | |
| EA200101206A1 (ru) | Применение биоразлагаемых микросфер, высвобождающих противораковый агент, для лечения глиобластомы | |
| TW202200121A (zh) | 治療方法 | |
| CN107982217B (zh) | 一种包载疏水性药物的具靶向和放疗增敏双重功能脂质-聚合物、其制备方法及其应用 | |
| JP6712003B2 (ja) | 医薬組成物及びその使用 | |
| AU2019208238A1 (en) | Therapeutic Modifiers of the Reverse Mode of ATP Synthase | |
| IL173481A0 (en) | Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration | |
| US20160346211A1 (en) | Bioerodible silicon-based delivery vehicles for delivery of therapeutic agents | |
| CN109289054A (zh) | 一种特异靶向骨组织的plga-peg-zol载药纳米材料及其制备方法 | |
| BRPI0418879A (pt) | formulação de dosagem por agente de constrate pelo ultra-som | |
| BR0015149A (pt) | Método e composições para administração de taxanos oralmente a pacientes humanos | |
| CN1265786C (zh) | 式ⅰ的化合物和紫杉醇在制备用于治疗癌症疾病的药物中的用途 | |
| Shah | Sildenafil in the treatment of erectile dysfunction | |
| HK1086474A1 (en) | Ultrasound contrast agent dosage formulation | |
| McMaster et al. | Blood Pressure Lowering Effect of Methylmethacrylate Monomer: Potentiation by Blood Volume Deficit. | |
| Bocci | Does ozone really “cure” cancer? | |
| Luo et al. | Biomineral-binding liposomes with dual antibacterial effects for preventing and treating dental caries | |
| US8318794B2 (en) | Method of use of porphyrins in preparing a medicament for sonodynamic therapy and a method of sonodynamic therapy using porphyrins | |
| JP2014502608A5 (de) | ||
| JPH01221316A (ja) | 脳循環代謝改善剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20140615 |